This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

IMRIS Sponsoring Practical Clinic And Exhibiting Intraoperative MR And CT Imaging Techniques At AANS

Solutions provide on-demand access to state-of-the-art imaging during procedures

MINNEAPOLIS, April 1, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced sponsorship of a Practical Clinic on brain mapping and awake surgical mapping techniques and exhibition at the American Association of Neurological Surgeons (AANS) 2014 scientific meeting April 5-9 in San Francisco.

Consistent with the conference's overarching theme and the mission of IMRIS of expanding neurosurgery, the course will review current technologies and challenges for pre-operative and intraoperative brain mapping for tumors and epilepsy. The IMRIS VISIUS ® intraoperative MRI is one of the technologies currently used effectively in these applications. AANS visitors are encouraged to learn more about IMRIS products at booth 913.

The global leader in intraoperative imaging solutions, IMRIS products give surgeons on-demand access to real-time data and state-of-the-art imaging during the procedure in the operating room (OR) without moving the patient. VISIUS Surgical Theatres by IMRIS are equipped with either high-field MR or 64-slice computed tomography (CT) that moves to the patient on ceiling-mounted rails. The Company also designs and manufactures proprietary head fixation devices, horseshoe headrests, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment.

"Our advanced systems integrate the latest MR and CT scanner technology within the surgical suite," said IMRIS President and CEO Jay D. Miller. "Growing clinical evidence and neurosurgical applications using our systems are showing that having immediate access to diagnostic quality imaging without moving the patient during surgery is valuable for improved patient outcomes and reduced risks."

About IMRIS IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 57 leading medical institutions around the world.

SOURCE IMRIS Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs